The U.S. live cell imaging market grows with demand in cancer research, drug discovery, and regenerative medicine. Technological advances in microscopy and AI-powered analysis improve cell monitoring. Academic and biopharma investment supports expansion. High equipment costs challenge smaller labs, but rising biotech funding fuels overall market momentum.
Read More: https://www.imarcgroup.com...